Stocks
Amicus Therapeutics (FOLD) EV/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -6.32 | -24.4 | -15.2 | -18.5 | -47.2 | -383.7 | ||
| Changes by years, y/y, % | +25% | +287% | -38% | +21% | +155% | +56.4% | |||
Amicus Therapeutics. EV/EBITDA
Amicus Therapeutics. EV/EBITDA, changes, %
Amicus Therapeutics (FOLD) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EV/EBITDA | ? | -29.0 | -47.9 | -47.5 | -79.3 | -375.1 | -383.7 | |
| Changes by years, y/y, % | +92% | +156% | +130% | +183% | +1 191% | |||
| Changes by quarters, q/q, % | +4% | +65% | -1% | +67% | +373% | |||
